Clinical Trial Update: Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A) [Phase 4]

View source ↗

Summary

A Phase 4 pediatric trial assessed the risk of essential fatty acid deficiency in children receiving Clinolipid versus standard-of-care lipid emulsion, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Fatty Acid Deficiency

Drugs mentioned

• CLINOLIPID (Olive Oil and Soybean Oil)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Essential Fatty Acid Deficiency (EFAD) | Phase 4 | Status: COMPLETED | Results posted: 2023-12-27